Chinese digital PCR instrument developer Rain Sure Biotech raised tens of millions of Yuan in a series A round funding led by Bio Venture, and followed by Future Capital and Volcanics Capital. The investment will be used on product R&D and launch of sales channels.
Established in 2017, Rain Sure Biotech combines micro-fluidics, optics, precise instruments, electric engineering, and biomedical technology to develop digital PCR instruments, reagent, and materials which will be used on molecular biotechnology related to DNA.
South Africa Today